CompletedNCT01263548
Lisdexamfetamine Use in Adults With ADHD and Bipolarity
About this title
Read the official source — NCT01263548Observational studyAges 18–55Canada
Understand this study
Who was this study for?
Listed age limits: 18 years to 55 years.
- Listed locations
- TorontoSee all locations and recruitment
Study information
Study start dateOctober 2010
- Recruitment status
- Completed
- Enrollment listed in the registry
- 45
- Sponsor
- University Health Network, Toronto
- Sponsor type
- University
- Study type
- Observational
- Intervention type
- Drug
- Locations
- Canada
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT01263548
- Official title
Show the full official title
To Evaluate the Safety and Metabolic Profile of Vyvanse for the Treatment of ADHD in Euthymic Adults With Bipolar I/II Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Toronto
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University Health Network, Toronto, a university.
Did this study involve medication?
Yes. The study involved medication, including lisdexamfetamine dimesylate.
Who was this study for?
Listed age limits: 18 years to 55 years.
